Anti-inflammatory activity of cinnamon (C. zeylanicum and C. cassia) extracts - identification of E-cinnamaldehyde and o-methoxy cinnamaldehyde as the most potent bioactive compounds
- PMID: 25629927
- DOI: 10.1039/c4fo00680a
Anti-inflammatory activity of cinnamon (C. zeylanicum and C. cassia) extracts - identification of E-cinnamaldehyde and o-methoxy cinnamaldehyde as the most potent bioactive compounds
Abstract
Chronic inflammation is a contributing factor in many age-related diseases. In a previous study, we have shown that Sri Lankan cinnamon (C. zeylanicum) was one of the most potent anti-inflammatory foods out of 115 foods tested. However, knowledge about the exact nature of the anti-inflammatory compounds and their distribution in the two major cinnamon species used for human consumption is limited. The aim of this investigation was to determine the anti-inflammatory activity of C. zeylanicum and C. cassia and elucidate their main phytochemical compounds. When extracts were tested in LPS and IFN-γ activated RAW 264.7 macrophages, most of the anti-inflammatory activity, measured by down-regulation of nitric oxide and TNF-α production, was observed in the organic extracts. The most abundant compounds in these extracts were E-cinnamaldehyde and o-methoxycinnamaldehyde. The highest concentration of E-cinnamaldehyde was found in the DCM extract of C. zeylanicum or C. cassia (31 and 34 mg g(-1) of cinnamon, respectively). When these and other constituents were tested for their anti-inflammatory activity in RAW 264.7 and J774A.1 macrophages, the most potent compounds were E-cinnamaldehyde and o-methoxycinnamaldehyde, which exhibited IC₅₀ values for NO with RAW 264.7 cells of 55 ± 9 μM (7.3 ± 1.2 μg mL(-1)) and 35 ± 9 μM (5.7 ± 1.5 μg mL(-1)), respectively; and IC₅₀ values for TNF-α of 63 ± 9 μM (8.3 ± 1.2 μg mL(-1)) and 78 ± 16 μM (12.6 ± 2.6 μg mL(-1)), respectively. If therapeutic concentrations can be achieved in target tissues, cinnamon and its components may be useful in the treatment of age-related inflammatory conditions.
Similar articles
-
Quantification of flavoring constituents in cinnamon: high variation of coumarin in cassia bark from the German retail market and in authentic samples from indonesia.J Agric Food Chem. 2010 Oct 13;58(19):10568-75. doi: 10.1021/jf102112p. J Agric Food Chem. 2010. PMID: 20853872
-
Suppression effect of Cinnamomum cassia bark-derived component on nitric oxide synthase.J Agric Food Chem. 2002 Dec 18;50(26):7700-3. doi: 10.1021/jf020751f. J Agric Food Chem. 2002. PMID: 12475291
-
Antimicrobial activities of cinnamon oil and cinnamaldehyde from the Chinese medicinal herb Cinnamomum cassia Blume.Am J Chin Med. 2006;34(3):511-22. doi: 10.1142/S0192415X06004041. Am J Chin Med. 2006. PMID: 16710900
-
Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum.Crit Rev Food Sci Nutr. 2011 Jul;51(6):547-62. doi: 10.1080/10408391003699550. Crit Rev Food Sci Nutr. 2011. PMID: 21929331 Review.
-
[Research progress of trans-cinnamaldehyde pharmacological effects].Zhongguo Zhong Yao Za Zhi. 2015 Dec;40(23):4568-72. Zhongguo Zhong Yao Za Zhi. 2015. PMID: 27141665 Review. Chinese.
Cited by 16 articles
-
Cinnamon extract supplementation improves inflammation and oxidative stress induced by acrylamide: An experimental animal study.Avicenna J Phytomed. 2020 May-Jun;10(3):243-252. Avicenna J Phytomed. 2020. PMID: 32523879 Free PMC article.
-
Customised structural, optical and antibacterial characteristics of cinnamon nanoclusters produced inside organic solvent using 532 nm Q-switched Nd:YAG-pulse laser ablation.Opt Laser Technol. 2020 Oct;130:106331. doi: 10.1016/j.optlastec.2020.106331. Epub 2020 May 21. Opt Laser Technol. 2020. PMID: 32457554 Free PMC article.
-
Phytochemical Characterization and Chemotherapeutic Potential of Cinnamomum verum Extracts on the Multiplication of Protozoan Parasites In Vitro and In Vivo.Molecules. 2020 Feb 24;25(4):996. doi: 10.3390/molecules25040996. Molecules. 2020. PMID: 32102270 Free PMC article.
-
Nature's Derivative(s) as Alternative Anti-Alzheimer's Disease Treatments.J Alzheimers Dis Rep. 2019 Nov 21;3(1):279-297. doi: 10.3233/ADR-190137. J Alzheimers Dis Rep. 2019. PMID: 31867567 Free PMC article. Review.
-
Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.Inflamm Bowel Dis. 2020 May 12;26(6):820-842. doi: 10.1093/ibd/izz259. Inflamm Bowel Dis. 2020. PMID: 31833544
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Medical
